✦ LIBER ✦

Concurrent Cisplatin and Radiation Versus Cetuximab and Radiation for Locally Advanced Head-and-Neck Cancer

✍ Scribed by Lawrence Koutcher; Eric Sherman; Matthew Fury; Suzanne Wolden; Zhigang Zhang; Qianxing Mo; Laschelle Stewart; Karen Schupak; Daphna Gelblum; Richard Wong; Dennis Kraus; Jatin Shah; Michael Zelefsky; David Pfister; Nancy Lee

Book ID: 118455216
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 184 KB
Volume: 81
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2010.07.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Accelerated Hypofractionated Radiation v

Accelerated Hypofractionated Radiation vs. Standard Fractionated Radiation Concurrent with Cetuximab Chemotherapy in Locally Advanced Head and Neck Cancer (LAHNC)

✍ S.L. Galper; H. Deshpande; M.G. Rose; J. Colasanto; R. Decker 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Toxicity of cetuximab versus cisplatin c

Toxicity of cetuximab versus cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer (LAHNSCC)

✍ Lorraine Walsh; Charles Gillham; Mary Dunne; Ian Fraser; Donal Hollywood; John A 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Concurrent cisplatinum and radiation for

Concurrent cisplatinum and radiation for advanced head and neck cancer

✍ Arlene A. Forastiere 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 293 KB

Concomitant cisplatin and radical radiat

Concomitant cisplatin and radical radiation in locally advanced head & neck carcinoma

✍ S. B. Kamboj; H. S. Hooda; V. Kaushal; B. P. Das 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 412 KB

Concurrent cetuximab, cisplatin, and rad

Concurrent cetuximab, cisplatin, and radiation for squamous cell carcinoma of the head and neck in vitro

✍ Na Zhang; Kaisa Erjala; Jarmo Kulmala; Xueshan Qiu; Maria Sundvall; Klaus Eleniu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 275 KB

Phase 2 trial of concurrent 5-fluorourac

Phase 2 trial of concurrent 5-fluorouracil, hydroxyurea, cetuximab, and hyperfractionated intensity-modulated radiation therapy for locally advanced head and neck cancer

✍ Johnny Kao; Eric M. Genden; Vishal Gupta; Edelweiss L. Policarpio; Ryan J. Burri 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 362 KB